Steris (STE) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.99% |
| Dec 31, 2025 | 11.50% |
| Sep 30, 2025 | 6.23% |
| Jun 30, 2025 | 9.41% |
| Mar 31, 2025 | 4.56% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 6.81% |
| Jun 30, 2024 | 3.11% |
| Mar 31, 2024 | 3.75% |
| Dec 31, 2023 | 6.28% |
| Sep 30, 2023 | 6.46% |
| Jun 30, 2023 | -3.75% |
| Mar 31, 2023 | -6.99% |
| Dec 31, 2022 | -8.68% |
| Sep 30, 2022 | -11.18% |
| Jun 30, 2022 | -2.52% |
| Mar 31, 2022 | 68.18% |
| Dec 31, 2021 | 70.23% |
| Sep 30, 2021 | 78.08% |
| Jun 30, 2021 | 88.00% |
| Mar 31, 2021 | 134.62% |
| Dec 31, 2020 | 14.58% |
| Sep 30, 2020 | 13.52% |
| Jun 30, 2020 | 7.94% |
| Mar 31, 2020 | 20,664.41% |
| Dec 31, 2019 | 9.12% |
| Sep 30, 2019 | 3.61% |
| Jun 30, 2019 | 4.70% |
| Mar 31, 2019 | -99.61% |
| Mar 31, 2018 | -27.12% |